EBITDA: Income before interest, taxes, depreciation and amortization.
ProPhase Labs, Inc. (PRPH) had EBITDA of $-2.75M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$0.88M |
|
$-6.84M |
|
$1.01M |
|
$-0.12M |
|
$5.65M |
|
$-4.76M |
|
$-2.23M |
|
$-7.00M |
|
$-7.00M |
|
$-6.84M |
|
$-6.84M |
|
$-6.84M |
|
$-6.84M |
|
$-4.76M |
|
|
EBITDA |
$-2.75M |
41.54M |
|
41.54M |
|
$-0.16 |
|
$-0.16 |
|
| Balance Sheet Financials | |
$7.77M |
|
$2.35M |
|
$57.93M |
|
$65.70M |
|
$55.29M |
|
$0.96M |
|
$3.55M |
|
$58.84M |
|
$6.86M |
|
$-4.92M |
|
$6.86M |
|
41.54M |
|
| Cash Flow Statement Financials | |
$-7.11M |
|
$0.92M |
|
$5.92M |
|
$0.68M |
|
$0.41M |
|
$-0.27M |
|
$1.46M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.14 |
|
-- |
|
-- |
|
0.12 |
|
0.66 |
|
-13.93% |
|
-539.52% |
|
-539.52% |
|
-- |
|
-792.30% |
|
-774.52% |
|
$-6.99M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
3.78 |
|
0.27 |
|
334.72 |
|
-99.68% |
|
139.00% |
|
-10.41% |
|
-87.39% |
|
$0.17 |
|
$-0.17 |
|
$-0.17 |
|